Drug Accelerated Growth in Children With Dwarfism, Pharmaceutical Firm Says – New York Times


TheStreet.com
Drug Accelerated Growth in Children With Dwarfism, Pharmaceutical Firm Says
New York Times
An experimental drug, vying to become the first approved treatment for dwarfism, improved growth in children by a significant amount in a preliminary study, the drug’s developer, BioMarin Pharmaceutical, said on Wednesday. In the study, the 10 children
Why BioMarin Pharmaceutical Inc. Shares Are Jumping HigherMotley Fool
Mid-Afternoon Market Update: BioMarin Pharmaceutical Jumps Following Benzinga
General Report on BioMarin Pharmaceutical Inc (NASDAQ:BMRN)Street Report
TheStreet.com -Dakota Financial News -CNA Finance (press release)
all 86 news articles >>

Source: pharmaceutical – Google News

Sharing information is key – Pharmaceutical Business News UK. Social Commerce and Social Media Management playing a big part. Suaju Ltd